Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Statistics

Total Valuation

AXSM has a market cap or net worth of $6.67 billion. The enterprise value is $6.63 billion.

Market Cap	6.67B
Enterprise Value	6.63B

Important Dates

The next confirmed earnings date is Monday, November 3, 2025, before market open.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

AXSM has 49.90 million shares outstanding. The number of shares has increased by 3.38% in one year.

Current Share Class	49.90M
Shares Outstanding	49.90M
Shares Change (YoY)	+3.38%
Shares Change (QoQ)	+1.17%
Owned by Insiders (%)	1.14%
Owned by Institutions (%)	77.71%
Float	41.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.29
Forward PS	8.75
PB Ratio	92.02
P/TBV Ratio	344.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	11.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.93.

Current Ratio	1.57
Quick Ratio	1.45
Debt / Equity	2.93
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.65

Financial Efficiency

Return on equity (ROE) is -275.50% and return on invested capital (ROIC) is -42.36%.

Return on Equity (ROE)	-275.50%
Return on Assets (ROA)	-19.79%
Return on Invested Capital (ROIC)	-42.36%
Return on Capital Employed (ROCE)	-63.06%
Revenue Per Employee	$821,761
Profits Per Employee	-$336,057
Employee Count	683
Asset Turnover	0.91
Inventory Turnover	2.40

Taxes

Income Tax	-875,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.34% in the last 52 weeks. The beta is 0.48, so AXSM's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+50.34%
50-Day Moving Average	123.33
200-Day Moving Average	113.92
Relative Strength Index (RSI)	62.18
Average Volume (20 Days)	474,263

Short Selling Information

The latest short interest is 3.44 million, so 6.89% of the outstanding shares have been sold short.

Short Interest	3.44M
Short Previous Month	3.38M
Short % of Shares Out	6.89%
Short % of Float	8.19%
Short Ratio (days to cover)	7.28

Income Statement

In the last 12 months, AXSM had revenue of $561.26 million and -$229.53 million in losses. Loss per share was -$4.67.

Revenue	561.26M
Gross Profit	515.60M
Operating Income	-194.84M
Pretax Income	-230.40M
Net Income	-229.53M
EBITDA	-186.03M
EBIT	-194.84M
Loss Per Share	-$4.67

Balance Sheet

The company has $325.27 million in cash and $216.10 million in debt, giving a net cash position of $109.17 million or $2.19 per share.

Cash & Cash Equivalents	325.27M
Total Debt	216.10M
Net Cash	109.17M
Net Cash Per Share	$2.19
Equity (Book Value)	73.73M
Book Value Per Share	1.47
Working Capital	205.05M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 91.86%, with operating and profit margins of -34.71% and -40.89%.

Gross Margin	91.86%
Operating Margin	-34.71%
Pretax Margin	-41.05%
Profit Margin	-40.89%
EBITDA Margin	-33.15%
EBIT Margin	-34.71%
FCF Margin	n/a

Dividends & Yields

AXSM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.38%
Shareholder Yield	-3.38%
Earnings Yield	-3.41%
FCF Yield	n/a

Analyst Forecast

The average price target for AXSM is $174.47, which is 30.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$174.47
Price Target Difference	30.58%
Analyst Consensus	Strong Buy
Analyst Count	19
Revenue Growth Forecast (5Y)	47.01%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3